| Closed |
SWOG-8219 |
Evaluation of Combined or Sequential Chemo-Endocrine Therapy in the Treatment of Advanced Adenocarcinoma of the Prostate |
8/11/1984 |
10/1/1986 |
|
|
Published
|
| Closed |
SWOG-8935 |
Evaluation of Continuous Infusion Interleukin-2 (IL-2) in Patients with Squamous Cell Carcinoma of the Head and Neck, Phase II |
11/15/1990 |
6/15/1992 |
14% |
|
|
| Closed |
SWOG-8235 |
Evaluation of Continuous Infusion Vinblastine in Gastric Carcinoma. |
10/18/1983 |
2/1/1987 |
|
|
Published
|
| Closed |
SWOG-8237 |
Evaluation of Continuous Infusion Vinblastine Sulfate in Pancreatic Adenocarcinoma |
5/27/1983 |
3/22/1985 |
|
|
Published
|
| Closed |
SWOG-8030 |
Evaluation of DHAD in Advanced Squamous Cell Carcinoma of the Head and Neck |
10/20/1980 |
1/31/1983 |
|
|
Published
|
| Closed |
SWOG-8028 |
Evaluation of DHAD in Gynecologic Cancers |
10/20/1980 |
10/3/1984 |
|
|
Published
|
| Closed |
SWOG-8043 |
Evaluation of DHAD in Pancreatic Adenocarcinoma |
1/28/1981 |
8/17/1984 |
|
|
Published
|
| Closed |
SWOG-8031 |
Evaluation of DHAD in Refractory Multiple Myeloma |
11/21/1980 |
3/30/1983 |
|
|
Published
|
| Closed |
SWOG-8004 |
Evaluation of DHAD in Soft Tissue and Bone Sarcomas |
7/3/1980 |
7/28/1981 |
|
|
Published
|
| Closed |
SWOG-8371 |
Evaluation of Diamine (1,1-Cyclobutane-Dicarboxylato-(2)-0,0')-CSP-4-2)Platinum (CBDCA-NSC-241240) and Cis-Dichloro-Trans-Dihydroxy-Bis-(Isoprpylamine)-Platinum IV (CHIP-NSC-256927) for Patients with… |
12/22/1983 |
9/27/1985 |
|
|
Published
|
| Closed |
SWOG-8754 |
Evaluation of Didemnin B in Disseminated Malignant Melanoma |
1/15/1989 |
5/1/1990 |
|
|
Published
|
| Closed |
SWOG-8728 |
Evaluation of Didemnin B in Metastatic Adenocarcinoma of the Kidney |
1/1/1988 |
2/1/1989 |
|
|
Published
|
| Closed |
SWOG-8640 |
Evaluation of Didemnin-B or Trimetrexate in the Treatment of Metastatic or Recurrent Squamous Carcinoma of the Uterine Cervix |
10/1/1987 |
7/15/1990 |
88% |
|
Published
|
| Closed |
SWOG-8032 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Acute Leukemia |
10/22/1980 |
9/10/1982 |
|
|
Published
|
| Closed |
SWOG-8010 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Advanced Prostate Cancer |
7/2/1980 |
12/28/1981 |
|
|
|
| Closed |
SWOG-8011 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Patients with Advanced Renal Cell Carcinoma |
7/2/1980 |
4/14/1981 |
|
|
|
| Closed |
SWOG-8008 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Breast Cancer |
7/2/1980 |
9/10/1982 |
|
|
|
| Closed |
SWOG-8005 |
Evaluation of Dihydroxyanthracenedione (DHAD) in Refractory Malignant Lymphomas |
7/2/1980 |
5/10/1982 |
|
|
|
| Closed |
SWOG-8009 |
Evaluation of Diydroxythracenedione (DHAD) in Patients with Refractory Small Cell Lung Cancer |
7/3/1980 |
5/11/1982 |
|
|
Published
|
| Closed |
SWOG-9104 |
Evaluation of Doxorubicin/Vinblastine Combined with Inhibitors (Trifluoperazine/Verapamil) of P-Glycoprotein in Patients with Advanced Renal Cell Carcinoma, Phase II |
9/1/1992 |
9/1/1994 |
65% |
|
Published
|
